PharmaJet, Inc. (Golden, CO) specializes in the development and deployment of needle-free injection devices. The company is supporting the use of their intradermal, subcutaneous and intramuscular dosing systems in multiple studies around the world with traditional vaccines.
Recent work undertaken by PharmaJet and their research collaborators has shown the PharmaJet FDA 510(k)-cleared technology has great utility in the delivery of DNA Vaccines. In particular, thank you to Michael Royals, Linda McAllister and Chris Barbour for helping to facilitate the progression of their enabling technology into the hands of researchers in the general field of genetic immunization.
DNAvaccine.com routinely recognizes people, technologies, organizations and events that have made an impact in the industry. If you would like to make a nomination, please contact Victoria at victoria@dnavaccine.com.
